Qube Research & Technologies (QRT)’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-24
Closed -$17 4921
2024
Q1
$17 Hold
24
﹤0.01% 4275
2023
Q4
$42 Hold
24
﹤0.01% 4083
2023
Q3
$35 Buy
+24
New +$60 ﹤0.01% 3844
2022
Q4
Sell
-16,735
Closed -$66K 3115
2022
Q3
$66K Sell
16,735
-21,777
-57% -$134K ﹤0.01% 2078
2022
Q2
$213K Buy
+38,512
New +$315K ﹤0.01% 1710
2021
Q3
Sell
-22,364
Closed -$930K 2909
2021
Q2
$930K Buy
+22,364
New +$919K 0.01% 975

Other funds holding DMTK

Qube Research & Technologies (QRT)'s DMTK Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 24 shares — an estimated $17 sold.

Qube Research & Technologies (QRT) first reported a position in DMTK in Q2 2021 and held it in 6 quarters. The position peaked at $930K in Q2 2021. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 24 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $17.
  • Qube Research & Technologies (QRT) first reported a position in DermTech, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s DermTech, Inc. Common Stock position peaked at $930K in Q2 2021.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.